Treatment for stage 3 myeloma is typically divided into phases. The goal is to achieve a deep remission, meaning the cancer is undetectable. This is the first phase. Most patients receive a "triplet" ...

Rates of multiple myeloma (MM), the second most common blood cancer in the United States, are increasing and are twice as ...

Men with newly diagnosed multiple myeloma are twice as likely as women to have stage III disease, with more kidney damage and ...

Rates of multiple myeloma (MM), the second most common blood cancer in the United States, are increasing and are twice as ...

It’s important to know that at first, multiple myeloma may not cause any symptoms. Usually, it is only suspected after a routine blood test shows an abnormality. After the disease has progressed, ...

Experts discuss the critical challenges in accessing innovative treatments for relapsed refractory multiple myeloma, ...

Treatment for multiple myeloma has evolved significantly, with long-term survival increasingly within reach for many patients. Achieving optimal outcomes requires not only addressing symptoms but also ...

Explore the transformative potential of bispecific antibodies in multiple myeloma, offering hope for improved patient ...

Rates of multiple myeloma, the second most common blood cancer in the United States, are increasing and are twice as high in men than in women. A new study published by Wiley online in CANCER provides ...

Multiple myeloma is a chronic (long-term) blood cancer that affects plasma cells made in the bone marrow, which is spongy tissue found inside bones. While people with multiple myeloma can live for ...

Treating high-risk smoldering multiple myeloma with single-agent daratumumab (Darzalex) delayed progression to active myeloma, according to findings from the phase III AQUILA trial presented at the ...

Hip-hop and storytelling can enhance health communication, making messages resonate more authentically with underserved ...